Extended Field Radiation Therapy Versus Delayed Hormonal Therapy in Node Positive Prostatic Adenocarcinoma

Autor: Paulson, David F., Cline, Wayne A., Bruce Koefoot, R., Hinshaw, Wanda, Stephani, Stephen, Bissada, Nabil, Bourne, Richard, Byhardt, Roger, Canning, John, Ciavarra, Vincent, Clark, Samuel, Finney, Roy, Gardner, William, Greenlaw, Robert, Harris, D.R., Hickman, Bernard, Jensen, Ralph, Hickman, Bernard, Levan, John, Liebner, Edwin, Moffat, Nelson, Nickson, James, Olsson, Carl, Poole, Kenneth, Roswit, Bernard, Seal, Ulysses, Soloway, Mark, Turner, William, Ucmakli, Alptekin, Wallace, Keene, Weems, Lamar, Woodward, Kent
Zdroj: The Journal of Urology; May 1982, Vol. 127 Issue: 5 p935-937, 3p
Abstrakt: This study was undertaken to determine the disease control and survival advantage of either extended field megavoltage irradiation or delayed androgen ablation in a randomized clinical trial. Comparison of the 2treatments, using either time-to-first evidence of treatment failure or survival, demonstrates an advantage to extended fieldradiation.
Databáze: Supplemental Index